雪榕生物
(300511)
| 流通市值：30.74亿 | | | 总市值：36.08亿 |
| 流通股本：5.46亿 | | | 总股本：6.41亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 297,508,656.19 | 161,452,486.54 | 104,968,184.35 | 76,412,238.54 |
| 应收票据及应收账款 | 46,084,391.38 | 43,768,360.92 | 36,326,690.57 | 30,516,848.46 |
| 应收账款 | 46,084,391.38 | 43,768,360.92 | 36,326,690.57 | 30,516,848.46 |
| 预付款项 | 15,126,982.08 | 11,439,944.52 | 14,090,408.59 | 6,944,765.74 |
| 其他应收款合计 | 5,783,757.59 | 8,598,631.03 | 5,779,988.45 | 5,629,830.77 |
| 存货 | 399,988,353.87 | 371,681,031.33 | 373,450,732.37 | 341,559,734.47 |
| 一年内到期的非流动资产 | 4,204,928.49 | 4,108,828.46 | 4,339,553.39 | 4,241,317.82 |
| 其他流动资产 | 5,562,561.17 | 4,991,345.3 | 6,275,633.11 | 4,341,317.18 |
| 流动资产合计 | 774,259,630.77 | 606,040,628.1 | 545,231,190.83 | 469,646,052.98 |
| 非流动资产: | | | | |
| 长期应收款 | 5,979,577.81 | 7,456,965.88 | 7,268,405.91 | 7,246,798.71 |
| 其他非流动金融资产 | 12,046,795.26 | 12,046,795.26 | 12,008,446.3 | 12,008,446.3 |
| 固定资产 | 2,559,353,053.9 | 2,633,028,695.1 | 2,669,639,291.28 | 2,749,822,121.3 |
| 在建工程 | 30,301,836.45 | 20,280,413.46 | 46,058,483.46 | 50,063,642.54 |
| 使用权资产 | 9,757,624.54 | 10,304,461.15 | 10,538,529.74 | 10,755,081.44 |
| 无形资产 | 296,191,781.04 | 299,430,594.73 | 295,004,781.61 | 296,413,359.09 |
| 长期待摊费用 | 5,643,690.39 | 6,141,879.09 | 6,118,414.5 | 6,641,931.73 |
| 其他非流动资产 | 15,225,215.49 | 6,633,900.43 | 9,573,119.31 | 5,596,808.16 |
| 非流动资产合计 | 2,934,499,574.88 | 2,995,323,705.1 | 3,056,209,472.11 | 3,138,548,189.27 |
| 资产总计 | 3,708,759,205.65 | 3,601,364,333.2 | 3,601,440,662.94 | 3,608,194,242.25 |
| 流动负债: | | | | |
| 短期借款 | 366,895,874.23 | 856,086,588.46 | 320,338,213.13 | 310,132,688.6 |
| 应付票据及应付账款 | 259,580,435.97 | 320,954,687.54 | 326,860,245.71 | 299,507,169.85 |
| 其中：应付票据 | 16,343,210.03 | 5,503,210.03 | 4,248,666.9 | 2,955,743.04 |
| 应付账款 | 243,237,225.94 | 315,451,477.51 | 322,611,578.81 | 296,551,426.81 |
| 合同负债 | 10,824,518.12 | 6,472,983.78 | 13,088,983.42 | 16,371,190.2 |
| 应付职工薪酬 | 44,744,895.03 | 49,117,546.05 | 40,680,070.01 | 58,431,491.91 |
| 应交税费 | 4,866,599.01 | 4,657,748.9 | 6,554,884.89 | 5,000,604.68 |
| 其他应付款合计 | 326,535,559.38 | 397,024,725.79 | 412,145,721.59 | 440,787,665.38 |
| 一年内到期的非流动负债 | 163,615,297.57 | 122,483,619.34 | 233,417,815.22 | 387,505,648.42 |
| 流动负债合计 | 1,177,063,179.31 | 1,756,797,899.86 | 1,353,085,933.97 | 1,517,736,459.04 |
| 非流动负债: | | | | |
| 长期借款 | 739,696,235.11 | 219,982,215 | 786,784,235.11 | 802,184,215 |
| 租赁负债 | 16,649,574.24 | 21,072,401.34 | 21,283,578.11 | 21,010,077.08 |
| 长期应付款 | 30,886,951.11 | 32,839,464.88 | 32,958,389.11 | 32,958,786.35 |
| 递延收益 | 56,401,624.38 | 57,185,559.59 | 58,519,172.1 | 60,727,500.95 |
| 非流动负债合计 | 843,634,384.84 | 331,079,640.81 | 899,545,374.43 | 916,880,579.38 |
| 负债合计 | 2,020,697,564.15 | 2,087,877,540.67 | 2,252,631,308.4 | 2,434,617,038.42 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 640,847,016 | 640,847,016 | 627,062,907 | 597,631,469 |
| 其他权益工具 | - | - | 7,070,039.03 | 21,771,325.1 |
| 资本公积 | 1,314,139,612.15 | 1,314,061,399.11 | 1,258,021,251.25 | 1,139,309,331.77 |
| 其他综合收益 | -6,000,713.03 | -4,703,410.71 | -4,887,496.82 | -4,890,445.05 |
| 盈余公积 | 96,775,007.87 | 96,775,007.87 | 96,775,007.87 | 96,775,007.87 |
| 未分配利润 | -261,788,494.07 | -434,958,854.21 | -527,101,204.31 | -567,304,873.53 |
| 归属于母公司股东权益合计 | 1,783,972,428.92 | 1,612,021,158.06 | 1,456,940,504.02 | 1,283,291,815.16 |
| 少数股东权益 | -95,910,787.42 | -98,534,365.53 | -108,131,149.48 | -109,714,611.33 |
| 股东权益合计 | 1,688,061,641.5 | 1,513,486,792.53 | 1,348,809,354.54 | 1,173,577,203.83 |
| 负债和股东权益合计 | 3,708,759,205.65 | 3,601,364,333.2 | 3,601,440,662.94 | 3,608,194,242.25 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-16 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |